You are here

Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke

Last updated on February 18, 2019

FOR MORE INFORMATION
Study Location
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy
Sex
Male
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy as determined by the investigator on the basis of medical history, physical
examination, clinical laboratory test results, vital signs, and 12‑lead
electrocardiogram (ECG).

- Smoker of at least 1 pack or more of cigarettes per day (20 plus or minus 3
cigarettes) for more than 1 year as determined by history.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any diagnosed bleeding disorder.

- Any major surgical procedure within 6 months before study day 1.

- Any history of major bleeding (eg, bleeding peptic ulcer) within 1 year before study
day 1.

NCT00719069
Pfizer
Completed
Study Evaluating the Effects of PSI-697 on Platelets in Subjects Who Smoke

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now